At a glance
ClinicalIndex Comparison RecordN/ACompleted· 499 enrolled
Drug / intervention
ClotTrieverdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ClotTriever Outcomes (CLOUT) Registry
In Brief
An observational study evaluating ClotTriever for Deep Vein Thrombosis Leg and 3 related conditions. Completed, enrolled 499 participants across 43 sites.
Detailed Summary
Evaluate real world patient outcomes after treatment of acute, subacute, and chronic proximal lower extremity deep vein thrombosis (DVT) with the ClotTriever Thrombectomy System.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDeep Vein Thrombosis Leg, DVT, Chronic DVT of Lower Extremity, Acute DVT of Lower Extremity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartSep 2018
Primary CompletionMar 2022
Study CompletionJul 2024
TodayJul 2026
First PostedJul 2, 2018
Enrollment StartSep 1, 2018
Primary CompletionMar 25, 2022
Study CompletionJul 2, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 8 years ago
Interventions
ClotTrieverdevice
Thrombectomy